HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Cheng Selected Research

N-(3-oxododecanoyl)homoserine lactone

7/2021N-(3-oxododecanoyl)-homoserine lactone disrupts intestinal barrier and induces systemic inflammation through perturbing gut microbiome in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Cheng Research Topics

Disease

111Neoplasms (Cancer)
06/2022 - 03/2002
20Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2011
18Breast Neoplasms (Breast Cancer)
07/2022 - 11/2007
18Neoplasm Metastasis (Metastasis)
01/2022 - 06/2009
17Inflammation (Inflammations)
08/2022 - 07/2008
17Infections
02/2022 - 08/2014
13Pain (Aches)
01/2022 - 08/2009
12Hypoxia (Hypoxemia)
01/2021 - 02/2012
10Fibrosis (Cirrhosis)
01/2022 - 01/2016
10Wounds and Injuries (Trauma)
04/2021 - 01/2004
9Melanoma (Melanoma, Malignant)
04/2022 - 02/2012
9Stroke (Strokes)
01/2022 - 01/2015
9Carcinogenesis
01/2022 - 07/2008
9COVID-19
01/2022 - 08/2020
8Lung Neoplasms (Lung Cancer)
01/2022 - 04/2015
8Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 10/2018
8Atrial Fibrillation
01/2021 - 04/2006
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020 - 02/2013
8Adenocarcinoma of Lung
01/2020 - 04/2010
7Prostatic Neoplasms (Prostate Cancer)
12/2021 - 01/2014
7Hyperalgesia
01/2020 - 10/2010
7Choledochal Cyst (Choledochal Cysts)
06/2019 - 10/2010
6Pneumonia (Pneumonitis)
08/2022 - 01/2011
6Carcinoma (Carcinomatosis)
03/2021 - 05/2008
6Hemorrhage
03/2021 - 04/2008
6Ischemic Stroke
01/2021 - 01/2017
5Dementia (Dementias)
08/2022 - 01/2022
5Mitochondrial Diseases (Mitochondrial Disease)
03/2022 - 02/2012
5Critical Illness (Critically Ill)
01/2022 - 09/2018
5Lymphatic Metastasis
05/2021 - 09/2010
5Dyspnea (Shortness of Breath)
01/2021 - 01/2020
5Acute Kidney Injury (Acute Renal Failure)
12/2020 - 01/2018
5Neuralgia (Stump Neuralgia)
01/2020 - 04/2012
4Pathologic Constriction (Stenosis)
12/2022 - 08/2011
4Cardiovascular Diseases (Cardiovascular Disease)
06/2022 - 04/2009
4Glioblastoma (Glioblastoma Multiforme)
01/2022 - 12/2017
4Virus Diseases (Viral Diseases)
01/2022 - 04/2021
4Schizophrenia (Dementia Praecox)
01/2022 - 01/2012
4Bacterial Infections (Bacterial Infection)
07/2021 - 01/2016
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2021 - 05/2019
4Tuberculosis (Tuberculoses)
02/2021 - 01/2016
4Leukemia
01/2021 - 07/2009
4Immunoglobulin Light-chain Amyloidosis
11/2020 - 01/2018
4Liver Neoplasms (Liver Cancer)
01/2020 - 05/2018
4Hypertension (High Blood Pressure)
08/2019 - 12/2002
4Fistula
01/2019 - 11/2014

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
06/2022 - 09/2010
23Pharmaceutical PreparationsIBA
06/2022 - 04/2010
19Messenger RNA (mRNA)IBA
06/2022 - 01/2011
19Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2011
13EnzymesIBA
06/2022 - 02/2010
13MicroRNAs (MicroRNA)IBA
02/2021 - 05/2015
11Small Interfering RNA (siRNA)IBA
03/2022 - 06/2009
10Biological ProductsIBA
08/2022 - 01/2015
10RNA (Ribonucleic Acid)IBA
01/2022 - 04/2010
9CytokinesIBA
08/2022 - 04/2011
8DNA (Deoxyribonucleic Acid)IBA
11/2019 - 08/2011
7Long Noncoding RNAIBA
01/2022 - 01/2018
6Indicators and Reagents (Reagents)IBA
06/2022 - 01/2019
6Therapeutic UsesIBA
01/2022 - 03/2014
6LigandsIBA
01/2022 - 04/2010
6Cisplatin (Platino)FDA LinkGeneric
04/2021 - 12/2019
6Glucose (Dextrose)FDA LinkGeneric
01/2021 - 06/2007
6Doxorubicin (Adriamycin)FDA LinkGeneric
12/2020 - 01/2017
6polydopamineIBA
01/2020 - 01/2017
6PolymersIBA
01/2019 - 07/2015
6ResveratrolIBA
12/2018 - 03/2013
5Circular RNAIBA
06/2022 - 01/2019
5Ion Channels (Ion Channel)IBA
04/2022 - 04/2006
5Phosphotransferases (Kinase)IBA
01/2022 - 11/2011
5GoldIBA
01/2022 - 01/2020
5CollagenIBA
01/2022 - 09/2005
5Transcription Factors (Transcription Factor)IBA
06/2021 - 01/2016
5Anti-Bacterial Agents (Antibiotics)IBA
03/2021 - 01/2016
5Oxygen (Dioxygen)IBA
01/2021 - 03/2013
5Amyloid (Amyloid Fibrils)IBA
11/2020 - 01/2018
5tocophersolanIBA
09/2018 - 01/2017
4Particulate MatterIBA
08/2022 - 01/2016
4Blood Glucose (Blood Sugar)IBA
01/2022 - 10/2013
4Polysaccharides (Glycans)IBA
01/2022 - 01/2009
4VaccinesIBA
12/2021 - 01/2016
4Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 01/2018
4CateninsIBA
08/2021 - 10/2013
4oxidized low density lipoproteinIBA
01/2021 - 11/2018
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 10/2011
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 09/2010
4Adenosine Triphosphatases (ATPase)IBA
01/2021 - 07/2009
4Contrast MediaIBA
09/2019 - 01/2018
4chenodeoxycholate sulfate conjugate (CDCS)IBA
06/2019 - 03/2012
4Docetaxel (Taxotere)FDA Link
01/2019 - 10/2017
4Succinic Acid (Succinate)IBA
09/2018 - 01/2017

Therapy/Procedure

66Therapeutics
06/2022 - 07/2008
16Drug Therapy (Chemotherapy)
06/2022 - 01/2016
10Length of Stay
01/2021 - 10/2010
7Artificial Respiration (Mechanical Ventilation)
01/2021 - 04/2008
6Operative Time
07/2021 - 10/2010
5Injections
12/2020 - 04/2013
5Spinal Injections
01/2020 - 08/2009
4Immunotherapy
01/2022 - 12/2021
4Operative Surgical Procedures
01/2019 - 11/2014